dDepartment of Bioanalytical Sciences, Plasma Product Development, Research & Development, CSL Behring, Australia ePlasma Product Development, Research & Development, CSL Behring AG, Bern, Switzerland ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Non-Commercial (NC): Only non-commercial uses of the work are permitted. Article Views ...

These results suggest that while LP.8.1 has lower pseudovirus infectivity than JN.1, its immune resistance is comparable to XEC and KP.3.1.1. NB.1.8.1 - This is the new mutation causing a spike in ...

such as pseudovirus assays and authentic assays; the company’s reliance on third parties with respect to virus assay creation and product candidate testing and with respect to its clinical ...

We demonstrate that displaying this sequence on the surface of supramolecular assemblies preserves its α-helical conformation and blocks the entry of a pseudovirus and its two variants into human host ...